Distinction of double seronegative neuromyelitis optica spectrum disease from AQP4-IgG seropositive and MOG-IgG seropositive cases in Asian patients

被引:0
|
作者
Kim, H. W. [1 ]
Lee, E. J. [1 ]
Lee, S. [1 ]
Kim, H. [1 ]
Kim, S. K. [1 ]
Kim, S. [1 ]
Choi, L. [1 ]
Lim, Y. M. [1 ]
Kim, K. K. [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1092
引用
收藏
页码:587 / 587
页数:1
相关论文
共 50 条
  • [1] Brain MRI abnormalities in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorder
    Schmidt, F.
    Borisow, N.
    Ruprecht, K.
    Bellmann-Strobl, J.
    Brandt, A.
    Paul, F.
    Scheel, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 636 - 636
  • [2] Neuromyelitis optica spectrum disorders: comparison of clinical and MRI characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands
    van Pelt, E. D.
    Wong, Y. Y.
    Ketelslegers, I. A.
    Hamann, D.
    Hintzen, R. Q.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 372 - 372
  • [3] Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
    Schmidt, Felix A.
    Chien, Claudia
    Kuchling, Joseph
    Bellmann-Strobl, Judith
    Ruprecht, Klemens
    Siebert, Nadja
    Asseyer, Susanna
    Jarius, Sven
    Brandt, Alexander U.
    Scheel, Michael
    Paul, Friedemann
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11
  • [4] Seroreversion in AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorder
    Kuempfel, Tania
    Oswald, Eva
    Havla, Joachim
    Engels, Daniel
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 670 - 670
  • [5] Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands
    van Pelt, E. D.
    Wong, Y. Y. M.
    Ketelslegers, I. A.
    Hamann, D.
    Hintzen, R. Q.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (03) : 580 - 587
  • [6] Effectiveness of mycophenolate mofetil as first line therapy in AQP4-IgG, MOG-IgG and seronegative neuromyelitis optica spectrum disorders
    Montcuquet, A.
    Collongues, N.
    Papeix, C.
    Zephir, H.
    Audoin, B.
    Laplaud, D.
    Bourre, B.
    Brochet, B.
    Camdessanche, J-P
    Labauge, P.
    Moreau, T.
    Stankoff, B.
    De Seze, J.
    Vukusic, S.
    Marignier, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 282 - 283
  • [7] Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
    Tradtrantip, Lukmanee
    Yeaman, Michael R.
    Verkman, A. S.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
    Lukmanee Tradtrantip
    Michael R. Yeaman
    A. S. Verkman
    [J]. Scientific Reports, 11
  • [9] A multi-facet comparative analysis of neuromyelitis optica spectrum disorders in patients with seropositive and seronegative AQP4-IgG
    Wang, Xiaojuan
    Chen, Xiaoyang
    Zhu, Chaoxia
    Ma, Haichang
    Wang, Fang
    Qin, Lingzhi
    Li, Wei
    [J]. MEDICINE, 2018, 97 (48)
  • [10] Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
    Montcuquet, Alexis
    Collongues, Nicolas
    Papeix, Caroline
    Zephir, Helene
    Audoin, Bertrand
    Laplaud, David
    Bourre, Bertrand
    Brochet, Bruno
    Camdessanche, Jean-Philippe
    Labauge, Pierre
    Moreau, Thibault
    Brassat, David
    Stankoff, Bruno
    de Seze, Jerome
    Vukusic, Sandra
    Marignier, Romain
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (10) : 1377 - 1384